Showing results (221-230 of 450) with videos related to
Sort By:
Pageof 45
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cellsM P Colombo, L Lombardi, A Stoppacciaro, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1994
Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patientsA Boiardi, A Silvani, P A Ruffini, et al.The Journal of Experimental Medicine|April 1, 1991
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivoM P Colombo, G Ferrari, A Stoppacciaro, et al.International Journal of Cancer|March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotypeL Rivoltini, G Cattoretti, F Arienti, et al.Blood|March 1, 1993
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cellsC Gambacorti-Passerini, F Grignani, F Arienti, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1996
Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccinesM Rodolfo, C Zilocchi, C Melani, et al.Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.Tumori|August 31, 1986
Infusion of autologous alloactivated lymphocytes in melanoma patients: toxicity and immunologic monitoringC Gambacorti-Passerini, R Marolda, G Tona, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytesG Fossati, A Balsari, D Taramelli, et al.Cancer Research|February 24, 2001
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsC Castelli, A M Ciupitu, F Rini, et al.Pageof 45